Exact Mass: 658.2305

Exact Mass Matches: 658.2305

Found 23 metabolites which its exact mass value is equals to given mass value 658.2305, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

xyloccensin T

xyloccensin T

C33H38O14 (658.2261)


   

61,63-di-O-methylneoagarotetraose

61,63-di-O-methylneoagarotetraose

C26H42O19 (658.232)


   

oregonoside B

oregonoside B

C33H38O14 (658.2261)


   

22,24-di-O-methylneoagarotetraose

22,24-di-O-methylneoagarotetraose

C26H42O19 (658.232)


   

Benzyl glycoside,4,6-O-benzylidene,2,3,3,4-tetra-Ac-alpha-Pyranose-2-O-beta-D-Xylopyranosyl-D-mannose

Benzyl glycoside,4,6-O-benzylidene,2,3,3,4-tetra-Ac-alpha-Pyranose-2-O-beta-D-Xylopyranosyl-D-mannose

C33H38O14 (658.2261)


   

decarbamoyl enacyloxin IIa

decarbamoyl enacyloxin IIa

C32H44Cl2O10 (658.2311)


   
   

Sutchuenmedin A

3-[(2S,3R,4R,5R,6S)-4,5-Dihydroxy-6-methyl-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-methoxyphenyl)-8,8-dimethylpyrano[2,3-h]chromen-4-one

C33H38O14 (658.2261)


   

5-(4-Carboxyphenyl)-10,15,20-triphenylporphyrin

5-(4-Carboxyphenyl)-10,15,20-triphenylporphyrin

C45H30N4O2 (658.2369)


   
   

Foscenvivint

Foscenvivint

C33H35N6O7P (658.2305)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor

   

3-[(8R,13R)-18-(2-carboxyethyl)-8,13-bis(carboxymethyl)-3,8,13,17-tetramethyl-7,12-dioxo-21,24-dihydroporphyrin-2-yl]propanoic acid

3-[(8R,13R)-18-(2-carboxyethyl)-8,13-bis(carboxymethyl)-3,8,13,17-tetramethyl-7,12-dioxo-21,24-dihydroporphyrin-2-yl]propanoic acid

C34H34N4O10 (658.2275)


   

24-[2-(2,5-Dioxopyrrolidin-1-yl)oxy-2-oxoethyl]-5,5,27,27-tetramethyl-16-oxa-20-aza-12-azoniaheptacyclo[15.11.0.03,15.04,12.06,11.020,28.021,26]octacosa-1(28),2,4(12),6(11),7,9,21(26),22,24-nonaene-8-sulfonic acid

24-[2-(2,5-Dioxopyrrolidin-1-yl)oxy-2-oxoethyl]-5,5,27,27-tetramethyl-16-oxa-20-aza-12-azoniaheptacyclo[15.11.0.03,15.04,12.06,11.020,28.021,26]octacosa-1(28),2,4(12),6(11),7,9,21(26),22,24-nonaene-8-sulfonic acid

C35H36N3O8S+ (658.2223)


   

3-(4-chloro-3h-imidazol-2-yl)-2-({2-[(1,4-dihydroxy-2-{[hydroxy(3-hydroxypiperidin-2-yl)methylidene]amino}-5-(c-hydroxycarbonimidoyloxy)pentylidene)amino]-1-hydroxy-3-(2-imino-1,3-dihydroimidazol-4-yl)propylidene}amino)-3-hydroxypropanoic acid

3-(4-chloro-3h-imidazol-2-yl)-2-({2-[(1,4-dihydroxy-2-{[hydroxy(3-hydroxypiperidin-2-yl)methylidene]amino}-5-(c-hydroxycarbonimidoyloxy)pentylidene)amino]-1-hydroxy-3-(2-imino-1,3-dihydroimidazol-4-yl)propylidene}amino)-3-hydroxypropanoic acid

C24H35ClN10O10 (658.2226)


   

(3s,6r,10r,13e,16s)-10-[(3,5-dichloro-4-hydroxyphenyl)methyl]-9,12-dihydroxy-6-methyl-3-(2-methylpropyl)-16-[(2r,3e)-4-phenylbut-3-en-2-yl]-1,4-dioxa-8,11-diazacyclohexadeca-8,11,13-triene-2,5-dione

(3s,6r,10r,13e,16s)-10-[(3,5-dichloro-4-hydroxyphenyl)methyl]-9,12-dihydroxy-6-methyl-3-(2-methylpropyl)-16-[(2r,3e)-4-phenylbut-3-en-2-yl]-1,4-dioxa-8,11-diazacyclohexadeca-8,11,13-triene-2,5-dione

C34H40Cl2N2O7 (658.2212)


   

10-[(3,5-dichloro-4-hydroxyphenyl)methyl]-9,12-dihydroxy-6-methyl-3-(2-methylpropyl)-16-(4-phenylbut-3-en-2-yl)-1,4-dioxa-8,11-diazacyclohexadeca-8,11,13-triene-2,5-dione

10-[(3,5-dichloro-4-hydroxyphenyl)methyl]-9,12-dihydroxy-6-methyl-3-(2-methylpropyl)-16-(4-phenylbut-3-en-2-yl)-1,4-dioxa-8,11-diazacyclohexadeca-8,11,13-triene-2,5-dione

C34H40Cl2N2O7 (658.2212)


   

methyl 2-[(1r,3r,4r,5r,10s,14s,15r,18s,19r,20r,22s)-3,22-bis(acetyloxy)-5-(furan-3-yl)-15,16-dihydroxy-4,12,18,20-tetramethyl-7-oxo-6,11,13,21-tetraoxaheptacyclo[10.8.1.1¹⁵,¹⁸.0¹,¹⁰.0⁴,⁹.0¹⁰,¹⁴.0¹⁶,²⁰]docos-8-en-19-yl]acetate

methyl 2-[(1r,3r,4r,5r,10s,14s,15r,18s,19r,20r,22s)-3,22-bis(acetyloxy)-5-(furan-3-yl)-15,16-dihydroxy-4,12,18,20-tetramethyl-7-oxo-6,11,13,21-tetraoxaheptacyclo[10.8.1.1¹⁵,¹⁸.0¹,¹⁰.0⁴,⁹.0¹⁰,¹⁴.0¹⁶,²⁰]docos-8-en-19-yl]acetate

C33H38O14 (658.2261)


   

(1r,4ar,12ar)-3-acetyl-4a-{[(2s,4r,5r,6r)-4-{[(2s,4r,5r,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-5-hydroxy-6-methyloxan-2-yl]oxy}-4,6,7-trihydroxy-1-methoxy-12,12a-dihydro-1h-tetracene-2,5-dione

(1r,4ar,12ar)-3-acetyl-4a-{[(2s,4r,5r,6r)-4-{[(2s,4r,5r,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-5-hydroxy-6-methyloxan-2-yl]oxy}-4,6,7-trihydroxy-1-methoxy-12,12a-dihydro-1h-tetracene-2,5-dione

C33H38O14 (658.2261)


   

[(2r,3s,4s,5r,6r)-6-{[(3s)-1,7-bis(3,4-dihydroxyphenyl)-5-oxoheptan-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl 4-hydroxy-3-methoxybenzoate

[(2r,3s,4s,5r,6r)-6-{[(3s)-1,7-bis(3,4-dihydroxyphenyl)-5-oxoheptan-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl 4-hydroxy-3-methoxybenzoate

C33H38O14 (658.2261)


   

3-acetyl-4a-({4-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-5-hydroxy-6-methyloxan-2-yl}oxy)-4,6,7-trihydroxy-1-methoxy-12,12a-dihydro-1h-tetracene-2,5-dione

3-acetyl-4a-({4-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-5-hydroxy-6-methyloxan-2-yl}oxy)-4,6,7-trihydroxy-1-methoxy-12,12a-dihydro-1h-tetracene-2,5-dione

C33H38O14 (658.2261)


   

methyl (2s)-2-[(1r,3r,4r,5r,10s,12r,14s,15s,16r,18s,19r,20s,22s)-3,22-bis(acetyloxy)-5-(furan-3-yl)-16-hydroxy-4,12,18,20-tetramethyl-7-oxo-6,11,13,21-tetraoxaheptacyclo[10.8.1.1¹⁵,¹⁸.0¹,¹⁰.0⁴,⁹.0¹⁰,¹⁴.0¹⁶,²⁰]docos-8-en-19-yl]-2-hydroxyacetate

methyl (2s)-2-[(1r,3r,4r,5r,10s,12r,14s,15s,16r,18s,19r,20s,22s)-3,22-bis(acetyloxy)-5-(furan-3-yl)-16-hydroxy-4,12,18,20-tetramethyl-7-oxo-6,11,13,21-tetraoxaheptacyclo[10.8.1.1¹⁵,¹⁸.0¹,¹⁰.0⁴,⁹.0¹⁰,¹⁴.0¹⁶,²⁰]docos-8-en-19-yl]-2-hydroxyacetate

C33H38O14 (658.2261)


   

(6-{[1,7-bis(3,4-dihydroxyphenyl)-5-oxoheptan-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methyl 4-hydroxy-3-methoxybenzoate

(6-{[1,7-bis(3,4-dihydroxyphenyl)-5-oxoheptan-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methyl 4-hydroxy-3-methoxybenzoate

C33H38O14 (658.2261)